Zurueck zur Suche

Reporte zur Charge UJ724AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

30Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
FL 3 KY 3 PA 3 IN 3 GA 2 NC 2 TN 2 IL 2 MT 1 AK 1 NJ 1 TX 1

VAERS 1932567

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

schwer
Staat
AK
Alter
55,0
Geschlecht
M
Eingang
08.12.2021
Impfdatum
29.10.2021
Beginn
01.11.2021
Tage bis Beginn
3,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Bell's palsy Ear discomfort Ear pain Facial paralysis Headache Otitis media

Symptomtext

around 11/01/2021 in the evening I began ear pain/pressure and sever headache. Saw PA on 11/03/2021 and I believe dx was otitis media. I was afebrile at that time. Pseudofed and OTC nasal spray recommended and started. During the onset and up to 11/06/2021 the ear pain/pressure, stabbing headache persisted. On 11/06/2021 in the a.m. Bell's Palsy started with facial paralysis. The ear ache/pain, headache, and most of the classic s/s of Bell's Palsy still persist. On 11/06/2021 reported to PA, steroids and antiviral added to medications. Gabapentin 300mg added at hs for sever headache. Flonase nasal added and OTC stopped . The 60 mg x5 , 40mg x 2 , 20mg x 2 prednisone completed, the 1 gm antiviral daily completed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
Dr. also seen in December
Aktuelle Erkrankungen
none
Vorgeschichte
paroxysmal Atrial fibrillation , heartburn
Andere Medikamente
Metoprolol 50 mg bid; famotidine 20 mg bid
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 1860701

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

schwer
Staat
IN
Alter
33,0
Geschlecht
M
Eingang
11.11.2021
Impfdatum
10.11.2021
Beginn
10.11.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cold sweat Dyskinesia Gaze palsy Hypoaesthesia Limb discomfort Nausea Paraesthesia Retching Seizure like phenomena Unresponsive to stimuli Urinary incontinence

Symptomtext

Within minutes of receiving Flublok, the patient became clammy, felt nauseous, and started dry heaving, Cool compresses were applied to back and neck, fan was turned on, cool water was given to drink. The patient requested to lie back so the chair was then put in a recline position. Soon after, his eyes rolled back in his head and he became unresponsive, slight jerking (seizure like) movements were observed for approximately 30 seconds. When he came to, he e said his arms felt heavy, and numb and tingly. He also experience slight bladder incontinence. After 15 minutes or so, the feeling in arms returned to normal. It's worth noting that the patient experienced a similar reaction following the COVID (J&J) vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure like phenomena
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Uknown
Vorgeschichte
Anxiety, Depression, Asthma
Andere Medikamente
Unknown
Allergien
eggs, nuts, penicillin, ibuprofen, gluten, COVID (J&J) vaccine
Vorherige Impfungen
-

VAERS 2188314

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

moderat
Staat
IN
Alter
28,0
Geschlecht
F
Eingang
18.03.2022
Impfdatum
19.10.2021
Beginn
19.11.2021
Tage bis Beginn
31,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Injection site paraesthesia Injection site reaction Pain

Symptomtext

I am having intermittent throbbing and tingling at injection site and it is sore to touch

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NA
Vorgeschichte
NA
Andere Medikamente
NA
Allergien
NA
Vorherige Impfungen
-

VAERS 1916513

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

moderat
Staat
PA
Alter
51,0
Geschlecht
F
Eingang
02.12.2021
Impfdatum
30.11.2021
Beginn
30.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dyspnoea Oedema Pruritus Urticaria

Symptomtext

Pruritus, hives, edema, shortness of breath, difficulty breathing Treatment: Benadryl, albuterol inhaler, singulair

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
Iodine, egg, latex, sulfa
Vorherige Impfungen
-

VAERS 1857967

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

moderat
Staat
ID
Alter
65,0
Geschlecht
F
Eingang
10.11.2021
Impfdatum
03.11.2021
Beginn
04.11.2021
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Feeling abnormal Sleep disorder Tremor

Symptomtext

Patient states she woke up in the middle of the night and she was shaking like she was having a convulsion. Her legs were straight and she was shaking very hard. It happened 4 times that night. She thinks she may have had a low grade fever, but she didn't take her temperature. It has not happened since, but she feels like she has had brain fog since that time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1814635

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

moderat
Staat
NY
Alter
45,0
Geschlecht
F
Eingang
25.10.2021
Impfdatum
21.10.2021
Beginn
21.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Blood test Computerised tomogram head Condition aggravated Echocardiogram Gait disturbance Hypersensitivity Hypoaesthesia Magnetic resonance imaging head normal Muscle spasms Paraesthesia Paraesthesia oral Pharyngeal paraesthesia Sensory loss Tricuspid valve incompetence Ultrasound Doppler

Symptomtext

Influenza Vaccine >/=18 Years, Quadrivalent, Preservative Free administered at work on 10/21/21 at around 3:15pm prior to going home for the day. At around 5:30pm on 10/21/21, felt left side of face, tongue and throat begin to tingle, left arm began to tingle as well as the left side of my body. Went to sleep that night and woke up around 4am on 10/22/21 to get ready for work, Got up from bed and stumbled unable to feel left side of my body especially legs and foot. Went to emergency room on 10/22/21. It was determined possible reaction to flu shot, however due to hospital policy a stroke needed to be ruled out and a code was called. Blood work and testing of limbs ensued. It was determined that they needed to observe me and run further tests to ensure a stroke or Transient ischemic attack (TIA) did not occur. Tingling of left side of face, tongue and throat have subsided, As of today 10/25/21, some sensation has returned to arm but spasms are occurring. Spasm of leg and foot are also occurring and there is still no sensation to the left leg and foot.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
1,0
Labordaten
Tests done: Multiplanar multisequential MR images of the brain, DX Chest Port Clinical History, ultrasound imaging of the bilateral carotid circulation, CT head scan without contrast, transthoracic echocardiography. Only findings were cardiac related including tricuspid valve regurgitation. Findings/Determination: Patient had allergic reaction from influenza vaccine.
Aktuelle Erkrankungen
Cardiac, murmur, tachycardia, tricuspid valve regurgitaion
Vorgeschichte
Cardiac, murmur, tachycardia, tricuspid valve regurgitaion
Andere Medikamente
Metroprolol
Allergien
Pears, Penicillins, Shellfish Containing Products, Sodium Phosphates, Peg-Electrolyte Soln, Polysorbate, Stevia
Vorherige Impfungen
Flu Vaccine,GlaxoSmithKline, Sep 11, 2020, Lot #:QFAA2021, Intramuscular: Left Deltoid

VAERS 2071759

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

mild
Staat
VA
Alter
55,0
Geschlecht
F
Eingang
28.01.2022
Impfdatum
13.10.2021
Beginn
14.10.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Burning sensation Pain in extremity

Symptomtext

Patient complained of a sore arm, burning, and some shoulder pain.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
Acquired Hypothyroidism, benign essential hypertension, environmental allergy, Raynaud's phenomenon, tinea pedis
Andere Medikamente
adapalene 0.1 %-benzoyl peroxide 2.5 % topical gel with pump, Aleve 220 mg tablet, Allegra Allergy, amLODIPine 10 mg tablet, B Complex, biotin, clobetasoL 0.05 % topical cream, dapsone 5 % topical gel, ketoconazole 2 % topical cream, Probi
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2001094

SEQIRUS, INC. · INFLUENZA (SEASONAL) (FLUAD QUADRIVALENT) · Charge UJ724AA

mild
Staat
TN
Alter
53,0
Geschlecht
F
Eingang
04.01.2022
Impfdatum
16.12.2021
Beginn
16.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site swelling

Symptomtext

Pt presented to clinic requesting seasonal influenza vaccine. Patient give Sanofi Pasteur Flu Quad Recomb Lot # UJ724AA per public health nurse. Pt returned to clinic approx 2 hours later and c/o redness and swelling to injection site on right deltoid.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NA
Vorgeschichte
NA
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1943695

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

mild
Staat
CA
Alter
52,0
Geschlecht
M
Eingang
13.12.2021
Impfdatum
13.12.2021
Beginn
13.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Eye swelling Urticaria

Symptomtext

post 24 hrs after administration , severe urticaria in head, face and neck and eyes with mild swelling to bilat eyes. took benadryl x 2 tabs during day and Claritin 1 tab. symptoms resolved later that night. no SOB

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
HTN x 2 yrs
Andere Medikamente
HTN meds Unknown name
Allergien
-
Vorherige Impfungen
Flu vaccine caused Asthma post 1 week, and J&J covid vaccine caused severe swelling to yes and face.

VAERS 1833541

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (OTHER) · Charge UJ724AA

mild
Staat
FL
Alter
45,0
Geschlecht
F
Eingang
01.11.2021
Impfdatum
14.10.2021
Beginn
15.10.2021
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Headache Nausea Pain Skin warm

Symptomtext

Shoulder to elbow very warm to touch, headache, nausea, body aches x4 days

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
diabetes, arthritis
Andere Medikamente
pantoprozale, cyclobenzaprine, diclofenac, ravustatin, losarten, neurontin, aspirin, lexapro
Allergien
sulfa, latex, gadolinium/mri contrast, eggs, some pain meds
Vorherige Impfungen
flu off and on for years

VAERS 1818618

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

mild
Staat
IN
Alter
40,0
Geschlecht
F
Eingang
26.10.2021
Impfdatum
26.10.2021
Beginn
26.10.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Dizziness Injection site erythema Injection site swelling Throat irritation Throat tightness Urticaria

Symptomtext

Within 10-15 minutes of receiving the injection, the patient developed significant swelling and redness at the site (described as baseball size), hives, tightening and irritation of throat though airway remained patent, dizziness.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
rash, environmental allergies
Vorgeschichte
hypothyroidism
Andere Medikamente
multivitamin
Allergien
indomethacin, Bactrim
Vorherige Impfungen
-

VAERS 1804365

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

mild
Staat
FL
Alter
57,0
Geschlecht
F
Eingang
21.10.2021
Impfdatum
19.10.2021
Beginn
20.10.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Axillary pain Body temperature increased Discomfort Fatigue Impaired work ability Lymphadenopathy Mammogram Pain

Symptomtext

The day after the vaccine onset swelling right axilla to half the size of an orange with moderate to severe pain, followed by a temperature of 100.4 degrees that night and generalized pain and fatigue the next day requiring time off work. Last year I took the same vaccine with no side effects. Earlier this year I ad these same side effects with 3 days of incapacitation after the second covid vaccine in March 2021. I then had swelling and discomfort in my left axilla intermittently for several months and my mammogram had to be repeated. I did not report it as no one said it was abnormal and I didn't know where to report it to. I believe that the vaccines are related or something has changed my system to react to the flu vaccine this way. I am using ibuprofen for pain and i'm not sure how long this will last this time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Axillary pain
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
hypertension, increased triglyceride levels, diabetes
Andere Medikamente
quinapril, rosuvastatin, fenofibrate, metformin, januvia; multivitamin with minerals, omega 3/6/9, vitamin C, docusate sodium, vitamin D3
Allergien
sulfa, adhesive tape, eggs, demerol
Vorherige Impfungen
COVID on 03/19/21 Mfg PFR Lot EN6200

VAERS 1705929

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

mild
Staat
PA
Alter
71,0
Geschlecht
F
Eingang
17.09.2021
Impfdatum
14.09.2021
Beginn
14.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Chills Fatigue Injection site pain Pyrexia

Symptomtext

Mild pain at injection site Mild fever Moderate Chills Severe joint pain Mild fatigue

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Diabetes, long lasting side effects from Moderna Covid 19 vaccine, hypothyroidism, sinus issues,
Vorgeschichte
See above
Andere Medikamente
Jardiance, levothyroxine, omeprazole, rosuvastatin, gabapentin, vitamin D, alpha lipoic acid, vitamin B complex, probiotics
Allergien
Penicillin
Vorherige Impfungen
Moderna Covid vaccine Jan/ Feb 2021 Same adverse effects as described above Severe for 48-72 hours but persisted to a milder d

VAERS 1694122

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

mild
Staat
TX
Alter
39,0
Geschlecht
M
Eingang
13.09.2021
Impfdatum
13.09.2021
Beginn
13.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pruritus Refusal of treatment by patient

Symptomtext

TIENT REQUESTED A FLUBLOK QUADRIVALENT IMMUNIZATION(INFLUENZA VACCINE). PATIENT WAS COUNSELLED ON POSSIBLE ADVERSE EVENTS AND GIVEN IMMUNIZATION AROUND 2:35PM THEN SAT FOR 15 MINUTES ON MONITORING. ONCE THE 15 MINUTES WERE COMPLETE THE PATIENT LEFT SATISFIED. PATIENT RETURNED WITH MOTHER TO THE PHARMACY AROUND 3:55PM STATING THAT HIS ARM WAS RED. THE PATIENT RAISED HIS SLEEVE TO SHOW A REDNESS UNDER THE IMMUNIZATION SITE. I ASKED THE PATIENT IF THEY HAD ANY TROUBLE BREATHING OR ITCHING AROUND THE AROUND OR INTERNALLY. PATIENT STATED THEY ONLY HAD THE REDNESS. THE PATIENT NOTICEABLY SCRATCHING WITH HIS NAILS I ASKED IF HE WOULD PLEASE HAVE A SIT AND LET ME ADMINISTER BENADRYL. PATIENT REFUSED STATE HE JUST WANT TO INFORM ME.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
PATIENT NEEDED OXYGEN MACHINE
Vorgeschichte
PATIENT REQUIRED OXYGEN MACHINE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 2000404

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

gering
Staat
NJ
Alter
-
Geschlecht
U
Eingang
03.01.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

temperature excursion occurred for a total of 86 hours and 30 minutes because the refrigerator was unplugged with no reported adverse event; Initial information received on 27-Dec-2021 regarding an unsolicited valid non-serious case received from a patient. This case involves an unknown demographics patient who experienced (product temperature excursion issue), temperature excursion occurred for a total of 86 hours and 30 minutes because the refrigerator was unplugged with no reported adverse event while receiving vaccines INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] and INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] and while treated with TUBERCULIN TEST [TUBERSOL]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient started taking TUBERSOL (TUBERCULIN TEST) (dose, formulation and strength not reported via unknown route in unknown administration site; lot - C5804AA, expiry: 03-Feb-2023, 17-Mar-2023) for Tuberculin test. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot UJ724AA, expiry: 30-Jun-2022 and INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE lot UJ759AD, expiry: 30-Jun-2022 via unknown route in unknown administration site (dose, formulation and strength not reported) as prophylactic vaccination. On an unknown date the patient developed a non-serious event "temperature excursion occurred for a total of 86 hours and 30 minutes because the refrigerator was unplugged with no reported adverse event" (product temperature excursion issue) (unknown latency) following the first dose intake of TUBERCULIN TEST, INFLUENZA QUADRIVALENT RECOMBINANT VACCINE and INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE. It was reported "Caller states that a temperature excursion occurred for a total of 86 hours and 30 minutes because the refrigerator was unplugged. The highest temperature reached was 70.0F(Fahrenheit). The products involved were unopened: FLUBLOK QUADRIVALENT, TUBERSOL, and FLUZONE HIGH-DOSE QUADRIVALENT. Caller asked for stability information for these products." Action taken with QUADRIVALENT RECOMBINANT INFLUENZA VACCINE (FLUBLOK QIV), TUBERCULIN TEST (TUBERSOL) and QUADRIVALENT INFLUENZA VACCINE (FLUZONE HIGH-DOSE QUADRIVALENT) was not applicable. It was not reported if the patient received a corrective treatment for the event (temperature excursion occurred for a total of 86 hours and 30 minutes because the refrigerator was unplugged with no reported adverse event). At time of reporting, the outcome was Unknown for the event temperature excursion occurred for a total of 86 hours and 30 minutes because the refrigerator was unplugged with no reported adverse event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
TUBERSOL
Allergien
-
Vorherige Impfungen
-

VAERS 1972032

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

gering
Staat
KY
Alter
17,0
Geschlecht
F
Eingang
22.12.2021
Impfdatum
26.09.2021
Beginn
26.09.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Incorrect dose administered Product administered to patient of inappropriate age

Symptomtext

Pt was given a Flublok vaccine at 17 years old. This vaccine is only indicated for 18 years and older. No known reactions occurred.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1970875

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

gering
Staat
IL
Alter
10,0
Geschlecht
F
Eingang
22.12.2021
Impfdatum
08.12.2021
Beginn
08.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

This case involves a 10-year-old female patient who was by mistakenly given dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] (product administered to patient of inappropriate age). The patient past medical history, medical treatment, vaccination and family history were not provided. Concomitant medications included NA (SODIUM). On 08-Dec-2021, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (lot UJ724AA and expiry date: 30-Jun-2022) (Oral solution) (0.25 mL to 2 mL for vaccines or 0.1 mL for TB skin test--0.5ml) (Frequency once) via intramuscular route in the right deltoid for prophylactic vaccination. It was an actual medication error case due to product administered to patient of inappropriate age (latency: same day). It was reported "FLUBLOK vaccine was given to a 10 year old and wants to know what would happen or do they need to give another age appropriate flu shot?". At the time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
NA
Allergien
-
Vorherige Impfungen
-

VAERS 1940098

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

gering
Staat
IL
Alter
10,0
Geschlecht
F
Eingang
10.12.2021
Impfdatum
08.12.2021
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

incorrect influenza vaccine administered to pediatric patient, no adverse event noted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
11/16/21 - lactose intolerance causing diarrhea
Vorgeschichte
allergic rhinitis, asthma, food allergy, eczema, atopic dermatitis
Andere Medikamente
albuterol inhaler 90 mcg/inh; albuterol 2.5 nebulization; fexofenadine 30 MG PO BID; flonase 30mg/5ml 1 spray BID; montelukast 5 mg PO HS; nasal spray PRN; triamcinolone 0.1% topical
Allergien
egg; fish; peanut; sesame seed; shellfish; tree nut; wheat
Vorherige Impfungen
-

VAERS 1935753

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

gering
Staat
FL
Alter
17,0
Geschlecht
M
Eingang
09.12.2021
Impfdatum
23.11.2021
Beginn
23.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient was given the Flublok that is for 18 and older rather than the fluzone for pediatrics. No adverse reactions ARNP notified

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Na
Vorgeschichte
NA
Andere Medikamente
NA
Allergien
Na
Vorherige Impfungen
-

VAERS 1895111

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

gering
Staat
NC
Alter
36,0
Geschlecht
F
Eingang
23.11.2021
Impfdatum
25.10.2021
Beginn
25.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Bursitis

Symptomtext

Patient returned to pharmacy 28 days post vaccination, expressed concerns about bursitis.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bursitis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1826295

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge uj724aa

gering
Staat
TN
Alter
17,0
Geschlecht
M
Eingang
28.10.2021
Impfdatum
28.10.2021
Beginn
28.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Wrong product administered

Symptomtext

Wrong vaccine given; no symptoms post injection

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
na
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
Zyrtec
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 1824762

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

gering
Staat
-
Alter
0,6
Geschlecht
M
Eingang
28.10.2021
Impfdatum
19.10.2021
Beginn
19.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Product administered to patient of inappropriate age

Symptomtext

A 8 months old patient received FLUBLOCK with no reported adverse event.; Initial information regarding an unsolicited valid non-serious case was received from Other Health Care Professional via a consumer/non-health care professional via regulatory authority (Reference number- 00822512) and transmitted to Sanofi on 21-Oct-2021. This case involves an 8-month-old male patient who was received INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] (product administered to patient of inappropriate age). The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had no other vaccine. On 19-Oct-2021, the patient received a 0.5 mL dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (lot UJ724AA, expiry: 30-Jun-2022, formulation: pre-filled syringe) via intramuscular route in unknown administration site for prophylactic vaccination. It was a case of an actual medication error due to inappropriate age at vaccine administration (latency same day). It was reported "The caller is asking recommendations for a patient given FLUBLOCK at 8 months old?" No other adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1821998

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

gering
Staat
MT
Alter
54,0
Geschlecht
F
Eingang
27.10.2021
Impfdatum
20.10.2021
Beginn
20.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hypoaesthesia oral

Symptomtext

Due to reported adverse COIV vaccine, had pt. sit on site 15: pt vistied with staff member additional 15 min, left, returned~ 10 min later c/o"numb lips and tongue" Pt had Bendadryl & took 50 mg po. Vitals stable o2 98% pulse 70, 150/80. Provided gatorade, no problem swallowing noted.Pt remained stable; sx resolved. Returned to work on site at her request.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hypoaesthesia oral
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Ibuprofen
Allergien
NKA Except bee stings
Vorherige Impfungen
Covid Vaccine, Unk date/type- lips numb/throat

VAERS 1813069

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

gering
Staat
GA
Alter
14,0
Geschlecht
M
Eingang
23.10.2021
Impfdatum
12.10.2021
Beginn
12.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

administered FLUBLOK to a 14 year old patient/ no AE; Initial information was received on 13-Oct-2021 regarding an unsolicited valid non-serious case from consumer/non-healthcare professional and physician via call center via Medical Information (Reference number- 00811402). This case involves a 14-year-old male patient who received INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] (product administered to patient of inappropriate age). The patient's medical history, past medical treatments, vaccinations, concomitant medication and family history were not provided. On 12-Oct-2021, the patient received a 0.5 mL dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (lot number: UJ724AA and expiry date: 30-Jun-2022) via an intramuscular route in the left deltoid for prophylactic vaccination. It was an actual medication error case due to inappropriate age at vaccine administration (latency: same day). It was reported "Clinical supervisor reports that one of their staff administered FLUBLOK to a 14 year old patient." At the time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1785575

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

gering
Staat
NM
Alter
46,0
Geschlecht
F
Eingang
14.10.2021
Impfdatum
11.10.2021
Beginn
11.10.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

The vaccine, Flublock Quadrivalent, was stored outside of the expected temperature range (36-46F) for 96 hours with a maximum temperature reaching 51.8F. The manufacturer, has reported that the product becomes invalid when stored in temperatures above 46F up to 72 hours or more. CDC recommendations are to have the employee re-vaccinate and may do so immediately, no need to wait. Employee notified of event. Unable to reschedule at this time, as our clinic is out of stock. To notify employee when restocked.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1765468

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

gering
Staat
PA
Alter
17,0
Geschlecht
F
Eingang
06.10.2021
Impfdatum
29.09.2021
Beginn
29.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

Flublok given to a 17 year old, patient feels okay, no side effects

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Aviane birth control
Allergien
KNDA
Vorherige Impfungen
-

VAERS 1758859

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

gering
Staat
NC
Alter
12,0
Geschlecht
F
Eingang
04.10.2021
Impfdatum
28.09.2021
Beginn
28.09.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Product administered to patient of inappropriate age

Symptomtext

A Flublok was given to a 12 year old. The appropriate age for Flublok is 18 years and up. The client did not have an adverse event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
-
Allergien
Latex, Tropical Fruit, Tree nuts, Peanuts, Eggs, bananas, and Avacados
Vorherige Impfungen
-

VAERS 1753255

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

gering
Staat
GA
Alter
56,0
Geschlecht
F
Eingang
01.10.2021
Impfdatum
28.09.2021
Beginn
29.09.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Erythema Peripheral swelling

Symptomtext

Extreme erythema and swelling of lower arm area

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
Unknown
Aktuelle Erkrankungen
None
Vorgeschichte
Hypercholesterolemia Hypertension
Andere Medikamente
Meloxicam, Atorvastatin, Valsartan, Vitamin D
Allergien
Doxycycline
Vorherige Impfungen
-

VAERS 1715045

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

gering
Staat
KY
Alter
17,0
Geschlecht
M
Eingang
20.09.2021
Impfdatum
11.09.2021
Beginn
11.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

FLUBLOK GIVEN- PT IS NOT OVER THE AGE OF 18, NO ADVERSE REACTIONS, MOTHER NOTIFIED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
FLONASE
Allergien
PCN
Vorherige Impfungen
-

VAERS 1715035

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ724AA

gering
Staat
KY
Alter
15,0
Geschlecht
F
Eingang
20.09.2021
Impfdatum
11.09.2021
Beginn
11.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

FLUBLOK ADMINISTERED , PT IS UNDER AGE OF 18, NO ADVERSE REACTIONS, MOTHER NOTIFIED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
FLONASE
Allergien
PCN
Vorherige Impfungen
-